Study Backs Claim that Certain Cancers are Caused by Viruses

Nov. 6, 2011 - PRLog -- According to a study published in April of this year in the Swiss medical journal, “Viruses” it is asserted that, “Retroviruses cause cancers in a variety of animals and humans.” This is something the Center for the Biology of Chronic Disease (CBCD) has argued for over eight years, ever since the Purple Book, written by Dr. Hanan Polansky was published.

According to Dr. Hanan Polansky’s discovery, most cases of cancer, heart disease, diabetes, arthritis, obesity, and many other chronic diseases are caused by an infection with a latent virus.

Some of these viruses are the Epstein-Barr virus (EBV), Cytomegalovirus (CMV), Herpes Simplex virus (HSV), Varicella Zoster virus (VZV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Papillomavirus (HPV), and others.

These viruses are genetic parasites. During their latent phase, they microcompete with the human genes, and in high concentrations, starve them, which forces the human genes to behave as if they have been mutated, that is, to malfunction.

This discovery, first presented by Dr. Hanan Polansky in his “Purple” book, has important implications. It suggests that we can cure and even prevent these diseases by targeting the latent viruses in the human body.

Today, the CBCD recommends prevention of latent viral transmission by every means possible. However, if one is already infected with a latent virus, one product on the market today stands out from the rest.

For those who wish to boost their immune systems against latent, viral invaders, the CBCD recommends Gene-Eden-VIR developed by biotechnology company, polyDNA.

Gene-Eden-VIR is the first, all natural, antiviral remedy scientifically designed to boost the immune system and help lower the concentrations of latent viruses within the body.

The CBCD recommends this remedy because of its record of safety and efficacy.

To date, in over 3 years of being on the market, there have been absolutely no side effects reported. Each Gene-Eden capsule contains a patented formula of five natural ingredients including selenium, camellia sinesis extract, quercetin, cinnamomum extract, and licorice extract, each at a uniquely selected dose. In addition, each bottle is GMP Certified.

Each ingredient was selected using the scientific method developed by Dr. Hanan Polansky. The scientists at polyDNA scanned thousands of scientific and medical papers published in various medical and scientific journals around the world, and identified the safest, most effective natural ingredients that target the most common, latent viruses of today.

In terms of price, in order to cut costs and to pass savings on Gene-Eden-VIR’S users, this dietary supplement is marketed exclusively online and is sold through the Gene-Eden website. Each bottle (a month’s supply) costs just $34.99.

“Gene-Eden combines several proven substances that work harmoniously to help boost the body’s own immune system or have other antiviral properties. The scientific data with regard to the immune enhancing and antiviral properties published in reputable sources on each individual compound in the Gene-Eden formula is impressive. Use of this product clearly has scientific merit based on published material.” – Dr. Norman Cohen, M.D.

Gene-Eden-VIR is the only product on the market today that scientifically boosts the immune system against latent viruses and that promotes overall wellness. To learn more about Gene-Eden-VIR or to schedule an interview with a polyDNA scientist, please visit www.Gene-Eden.com or call 585-250-9999.

# # #

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

The study referenced in the release above was published in April, 2011 in the Swiss medical journal, “Viruses” and is entitled: “Insertional oncogenesis by non-acute retroviruses: implications for gene therapy.”

An abstract of this article can be found on Pubmed.gov.